WebBiodiem Def share price and BDMN stock charts. Free real-time prices and the UK's most active stock market forums. Biodiem Def (BDMN) share price, charts, trades & the UK's … WebOct 18, 2012 · Melbourne, 18 October 2012: Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today that it continues to make solid progress on its antimicrobial program with advancing preclinical data, new partnerships in negotiation, and a number of new key patents strengthening BioDiem’s …
Global Influenza Vaccine Market 2024-2028 Size, Share, Growth …
WebJul 12, 2010 · Published: Jul 12, 2010. Melbourne, Monday 12 July 2010: (ASX: BDM) BioDiem Ltd’s lead product, the Live Attenuated Influenza Vaccine (LAIV) has been granted regulatory approval for marketing in India. “NasoVac” was launched this week by the Indian vaccine company, the Serum Institute of India (“SII”). This is the first approval for ... WebFeb 2, 2024 · BIODIEM LTD. (ASX:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BIODIEM LTD. Australian Stock Exchange: Australian Stock ... the western eye hospital
Life Sciences and Biotechnology Development and …
WebBiodiem Def share price and BDMN stock charts. Free real-time prices and the UK's most active stock market forums. Biodiem Def (BDMN) share price, charts, trades & the UK's … WebCompany profile page for Biodiem Ltd including stock price, company news, press releases, executives, board members, and contact information WebAug 7, 2012 · Published: Aug 07, 2012. Melbourne, 8 August 2012: Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, … the western fair